National Medicines Consolidated: Net profit for 2025 is 1.136 billion yuan, a year-on-year increase of 76.80%.

China National Pharmaceutical Group Corporation (Sinopharm) released its performance report, with a total operating revenue of 73.416 billion yuan in 2025, a decrease of 1.29% year-on-year; net profit was 1.136 billion yuan, an increase of 76.80% year-on-year. During the reporting period, the company achieved operating revenue of 73.416 billion yuan, a decrease of 1.29% year-on-year; operating profit was 1.513 billion yuan, an increase of 163.80% year-on-year; total profit was 1.509 billion yuan, an increase of 162.22% year-on-year; net profit attributable to shareholders of the listed company was 1.136 billion yuan, an increase of 76.80% year-on-year, with a corresponding basic earnings per share increase of 77.39% year-on-year; the weighted average return on net assets increased by 2.59 percentage points year-on-year.